A Phase l/IIa, randomized, double blind, placebo-controlled, parallel group, pilot study to assess the safety and efficacy of a therapeutic HSV-2 DNA vaccine in HSV-2 positive adults

Trial Profile

A Phase l/IIa, randomized, double blind, placebo-controlled, parallel group, pilot study to assess the safety and efficacy of a therapeutic HSV-2 DNA vaccine in HSV-2 positive adults

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Jan 2018

At a glance

  • Drugs Herpes simplex virus DNA vaccine (Primary)
  • Indications Herpes simplex virus type 2 infections
  • Focus Adverse reactions
  • Sponsors Admedus
  • Most Recent Events

    • 24 Jan 2018 Status changed from active, no longer recruiting to completed.
    • 19 Oct 2016 Interim results were published in the Admedus Media Release.
    • 04 Mar 2016 Interim results from the first 20 patients published in an Admedus media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top